IP Verse

Bilayer Tablet Formulations

PatentPatent Analysis

EP2498758

ASTRAZENECA
Application Number
EP10782113A
Filing Date
Nov 12, 2010
Status
Granted And Under Opposition
Jun 22, 2018
Grant Date
Jul 25, 2018
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP3045466B2
EP4175619B1
EP4175620B1

Bibliography

The patent EP2498758B1 was granted to Astrazeneca on Jul 25, 2018 following the initial filing on Nov 12, 2010 under the application number EP10782113A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions filed by Competitors

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

HOEFER & PARTNER PATENTANWALTE MBBApr 25, 2019WITHDRAWN

Dossier Documents of the Patent

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents